Key results
The company
Biofy Technologies
biofy.techAI-powered genomic platform for infection diagnosis and antibiotic resistance.
Result highlights
- 50% operational cost reduction via AI solution
- Diagnostic time cut from 5 days to 4 hours
- Patient death rate cut from 70% to 50%
The story
A Brazilian health tech startup manages 90TB of real and synthetic DNA data to identify bacterial infections and antibiotic resistance.
Traditional laboratory identification methods require up to five days to process results, a critical delay that risks patient survival in acute care settings. The existing workflows could not analyze vast, evolving genomic datasets quickly enough to guide immediate antibiotic treatment.
The company deployed Oracle Autonomous AI Database with AI Vector Search to securely store and index 90TB of genomic data. OCI Generative AI executes millisecond-level searches across these datasets to match DNA sequences against known bacterial strains and resistance markers. This architecture enables the platform to deliver precise diagnostic reports to clinicians in hours rather than days.
Quotes
“The Oracle AI solution and the product that we developed based on it allowed us to cut at least 50% of costs with almost 100% better performance. And, for us, speed—reducing the time it takes to have test results—is very important.”